Effect of simethicone for the management of early abdominal distension after laparoscopic cholecystectomy: a multicenter retrospective propensity score matching study

Table 3 Univariate and multivariate analyses of the factors affecting remission of abdominal distension 24 h after LC

Factors	Univariable analysis		Multivariable analysis
Factors	OR (95% CI)	P-value	OR (95% CI)	P-value
Gender, male	0.91 (0.69, 1.20)	0.507
Age	1.00 (0.99, 1.01)	0.843
Weight	1.00 (0.99, 1.01)	0.678
Gallstone	0.51 (0.35, 0.76)	0.001	0.33 (0.18, 0.62)	0.001
Cholecystitis	0.98 (0.74, 1.28)	0.856
Cholecystic polyp	1.17 (0.78, 1.76)	0.451	0.53 (0.28, 1.00)	0.050
Other gallbladder disease	1.74 (0.84, 3.64)	0.138
Preoperative abdominal distention	0.65 (0.50, 0.86)	0.003	0.63 (0.47, 0.85)	0.002
Hypertensive	0.86 (0.58, 1.28)	0.455
Hyperlipidemia	1.85 (0.90, 3.83)	0.097
Coronary heart disease	0.49 (0.13, 1.84)	0.289
Simethicone use	1.73 (1.29, 2.32)	< 0.001	1.89 (1.39, 2.58)	< 0.001
Diabetic mellitus	1.48 (0.77, 2.84)	0.240
Operating time	0.99 (0.98, 1.00)	< 0.001
Anesthesia duration	0.99 (0.99, 1.00)	< 0.001

Note: Multivariate indexes with significant differences were included to analyze the predicted value
CI, confidence interval; LC, laparoscopic cholecystectomy; OR, odds ratio

ISSN: 1471-2482